Neoplasms: all 9,616 studies

Page 34 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.CompletedNCT01789281Phase 4Results posted
• Phase II Maraviroc for GVHD PreventionCompletedNCT01785810Phase 2Results posted
• Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced MalignanciesCompletedNCT01781429Phase 1/2Results posted
• An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820 to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subjects With Unresectable Solid TumorsCompletedNCT01773421Phase 1Results posted
• Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)CompletedNCT01772004Phase 1Results posted
• NSAID Effects on Clinical and Imaging Breast BiomarkersCompletedNCT01761877Phase 2Results posted
• Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice PatientsTerminatedNCT01760941Not applicableResults posted
• Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow TransplantationTerminatedNCT01749293Phase 2Results posted
• AZD1775 for Advanced Solid TumorsCompletedNCT01748825Phase 1Results posted
• Schedules of Nab-Paclitaxel in Metastatic Breast CancerCompletedNCT01746225Phase 2Results posted
• Abatacept as GVHD Prophylaxis Phase 2CompletedNCT01743131Phase 2Results posted
• Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)CompletedNCT01742286Phase 1Results posted
• Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal TestingCompletedNCT01741363Not applicableResults posted
• An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib ProtocolCompletedNCT01739764Phase 4Results posted
• Imetelstat Sodium in Treating Participants With Primary or Secondary MyelofibrosisCompletedNCT01731951Phase 2Results posted
• MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity AddendumCompletedNCT01719562Not applicableResults posted
• [F-18] Fluorothymidine PET/CT Imaging for Pelvic CancersCompletedNCT01717391Phase 2Results posted
• An Observational Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Non-myeloid MalignancyCompletedNCT01716559Results posted
• A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid TumorsCompletedNCT01714739Phase 1/2Results posted
• Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or AnemiaCompletedNCT01712308Phase 2Results posted
• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsCompletedNCT01709435Phase 1Results posted
• A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid TumorsTerminatedNCT01708161Phase 1/2Results posted
• Interleukin-2 in Metastatic Kidney CancerTerminatedNCT01702909Phase 2Results posted
• Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime CohortCompletedNCT01700959Phase 3Results posted
• A Study of LY3039478 in Participants With Advanced CancerCompletedNCT01695005Phase 1Results posted
• Cabozantinib for Advanced Urothelial CancerCompletedNCT01688999Phase 2Results posted
• A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast CancerCompletedNCT01684215Phase 2Results posted
• A Study in Participants With Advanced Solid TumorsCompletedNCT01682135Phase 1Results posted
• Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).CompletedNCT01682083Phase 3Results posted
• PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon CancerCompletedNCT01681472Phase 1/2Results posted
• Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal CancerTerminatedNCT01681368Phase 2Results posted
• 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung CancerCompletedNCT01658813Phase 2Results posted
• CP-751,871 In Combination With Docetaxel In Advance Non-hematologic MalignanciesCompletedNCT01653158Phase 1Results posted
• Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.CompletedNCT01649271Phase 1Results posted
• A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has SpreadCompletedNCT01648764Phase 1Results posted
• A Study of IMC-TR1 in Participants With Advanced Solid TumorsCompletedNCT01646203Phase 1Results posted
• MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)CompletedNCT01643850Phase 2Results posted
• Study of Peretinoin for Suppressing Recurrence of HCV-positive HCCCompletedNCT01640808Phase 3Results posted
• Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC)CompletedNCT01640340Not applicableResults posted
• Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung CancerCompletedNCT01625234Phase 1/2Results posted
• A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid TumorsCompletedNCT01624467Phase 2Results posted
• Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast CancerCompletedNCT01622868Phase 2Results posted
• Clinical Study of WT2725 in Patients With Advanced MalignanciesCompletedNCT01621542Phase 1Results posted
• T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic TransplantTerminatedNCT01621477Phase 2Results posted
• Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid TumorsCompletedNCT01619865Phase 1/2Results posted
• Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With CancerCompletedNCT01618344Results posted
• Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor CancerCompletedNCT01607905Phase 1Results posted
• Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological CancerCompletedNCT01607892Phase 1Results posted
• A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-CisplatinCompletedNCT01606748Phase 2Results posted
• Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung CancerCompletedNCT01605916Phase 1Results posted
• A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.CompletedNCT01602380Phase 3Results posted
• Comparison of a Novel 22-gauge Core Biopsy NeedleCompletedNCT01598194Not applicableResults posted
• Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous SystemTerminatedNCT01596127Phase 1/2Results posted
• Cabozantinib in Advanced Solid MalignanciesCompletedNCT01588821Phase 2Results posted
• Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant LymphomaCompletedNCT01588548Phase 1Results posted
• Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination RegimenCompletedNCT01587040Phase 1/2Results posted
• Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic CancerCompletedNCT01582191Phase 1Results posted
• Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent GlioblastomaTerminatedNCT01582152Phase 1/2Results posted
• Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With MalignancyTerminatedNCT01580618Phase 2/3Results posted
• A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid TumoursCompletedNCT01578239Phase 3Results posted
• Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase CCompletedNCT01577758Phase 1Results posted
• A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid TumorsCompletedNCT01577745Phase 1Results posted
• Hepatic Impairment Study For Crizotinib In Advanced Cancer PatientsCompletedNCT01576406Phase 1Results posted
• A Study of Ramucirumab and Docetaxel in Participants With Solid TumorsCompletedNCT01567163Phase 2Results posted
• Positron Emission Tomography/Magnetic Resonance Imaging in PatientsTerminatedNCT01557881Not applicableResults posted
• GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell CancerCompletedNCT01553851Phase 2Results posted
• AMG 386 and Abiraterone for Advanced Prostate CancerCompletedNCT01553188Phase 2Results posted
• A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid TumorsCompletedNCT01543698Phase 1/2Results posted
• Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With CancerCompletedNCT01542879Phase 1/2Results posted
• Stereotactic Body Radiation Therapy (SBRT) for Prostate CancerCompletedNCT01540994Not applicableResults posted
• A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched RelativesTerminatedNCT01532635Phase 2Results posted
• De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell CaCompletedNCT01530997Phase 2Results posted
• Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver MetastasesCompletedNCT01528878Not applicableResults posted
• Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral CavityTerminatedNCT01525927Phase 2Results posted
• Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid TumorsCompletedNCT01525602Phase 1Results posted
• Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell TransplantationCompletedNCT01525407Phase 2Results posted
• A Dose-Escalation Study in Participants With Advanced CancerCompletedNCT01524224Phase 1Results posted
• Cancer Vaccine Targeting Brachyury Protein in TumorsCompletedNCT01519817Phase 1Results posted
• Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases StudyActive, not recruitingNCT01516710Not applicableResults posted
• Local Anesthetic Cream in Younger Patients Undergoing Lumbar PuncturesCompletedNCT01516684Phase 2Results posted
• A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid TumorsCompletedNCT01515306Phase 2Results posted
• Retrospective Study Assessment Treatment Response Faslodex®( 500 mg)CompletedNCT01509625Results posted
• Additive Homeopathy in Cancer PatientsCompletedNCT01509612Phase 3Results posted
• Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast CancerTerminatedNCT01499160Phase 2Results posted
• A Phase 1 Study of Dexanabinol in Patients With Advanced Solid TumoursCompletedNCT01489826Phase 1Results posted
• Imaging Study for FdCyd and THU Cancer TreatmentTerminatedNCT01479348Early Phase 1Results posted
• Sipuleucel-T Manufacturing Demonstration StudyCompletedNCT01477749Phase 2Results posted
• Safety and Tolerability of HSC835 in Patients With Hematological MalignanciesCompletedNCT01474681Phase 1/2Results posted
• First In Human, Phase 1 Study of AG013736 In Patients With Solid TumorsCompletedNCT01469052Phase 1Results posted
• Pazopanib and ARQ 197 for Advanced Solid TumorsCompletedNCT01468922Phase 1Results posted
• Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid TumorsCompletedNCT01466036Phase 2Results posted
• Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)TerminatedNCT01463696Phase 1Results posted
• Optical Imaging of Head and Neck CancerTerminatedNCT01456143Not applicableResults posted
• Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or LymphomaCompletedNCT01454076Phase 1Results posted
• MSC2015103B in Solid TumorsTerminatedNCT01453387Phase 1Results posted
• Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid TumorsCompletedNCT01447225Phase 1Results posted
• Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)CompletedNCT01446016Phase 2Results posted
• The Effects of Lycopene on High Risk Prostatic TissueCompletedNCT01443026Phase 2Results posted
• Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain MetastasesCompletedNCT01441596Phase 2Results posted
• ECI301 and Radiation for Advanced or Metastatic CancerTerminatedNCT01441115Phase 1Results posted

← Neoplasms overview